Cumberland Pharmaceuticals CPIX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's net income?
- Cumberland Pharmaceuticals (CPIX) reported net income of -$3.29M in Q1 2026.
- How has Cumberland Pharmaceuticals's net income changed year-over-year?
- Cumberland Pharmaceuticals's net income decreased by 361.7% year-over-year, from $1.26M to -$3.29M.
- What is the long-term trend for Cumberland Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's net income has grown at a -5.2% compound annual growth rate (CAGR), from -$3.51M to -$2.84M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.